United States· US:11994-001_d515f49a-8eb4-42f3-a7ee-1634a4804ca5
Cardiolite
A medicinal product containing tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate, registered in United States by Lantheus Medical Imaging, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE
- Manufacturer
- Lantheus Medical Imaging, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc11119940012020 VIAL in 1 BOX (11994-001-20) / 5 mL in 1 VIAL
- ndc1111994001555 VIAL in 1 BOX (11994-001-55) / 5 mL in 1 VIAL
- ndc1111994-001-20
- ndc1111994-001-55
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5d02bccf-a4a4-45ae-a305-a084b2435e87 GET /v1/drugs/5d02bccf-a4a4-45ae-a305-a084b2435e87?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "1",
"substance": "TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE",
"productndc": "11994-001",
"dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "NDA019785",
"marketing_category": "NDA"
}See everything about tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.